













Obagi Nu-Derm® Rx Transformation System for Normal to Dry Skin is a seven-product morning and evening skincare system containing Obagi Nu-Derm Clear and Blender, both formulated with hydroquinone USP 4%. The system combines prescription pigmentation treatment with cleansing, toning, exfoliation, moisturisation and broad-spectrum sun protection.
This version contains Gentle Cleanser and Exfoderm and is formulated for combination and normal-to-dry skin. It is distinct from the Normal-to-Oily system, which contains Foaming Gel and Exfoderm Forte.
The hydroquinone products within the system are indicated for the gradual lightening of melanin-related hyperpigmentation. The prescribing information identifies conditions including chloasma, melasma, freckles, senile lentigines—commonly described as age spots—and other unwanted areas of melanin hyperpigmentation.
The supporting products provide cleansing, toning, surface exfoliation, moisturisation and ultraviolet protection. Obagi identifies the Normal-to-Dry system for skin discoloration, dehydrated skin and visible features associated with sun-damaged or ageing skin, including roughness and sallowness.
A mild facial cleanser for combination and normal-to-dry skin. It removes makeup, surface oil and everyday impurities without using the Foaming Gel supplied in the Normal-to-Oily system.
An alcohol-free toner used after cleansing. It removes remaining surface impurities and prepares the skin for the subsequent Nu-Derm products.
A prescription cream containing hydroquinone USP 4%. Clear is the Step 3 product within the Nu-Derm routine and is labelled for morning and evening use unless prescribed otherwise.
A lightweight morning exfoliating lotion formulated for combination and normal-to-dry skin. It contains phytic acid and differs from the glycolic- and lactic-acid Exfoderm Forte supplied in the Normal-to-Oily system.
A prescription evening blending cream containing hydroquinone USP 4%. Blender is a separate formulation from Clear and occupies a different position within the Nu-Derm routine.
A facial moisturiser used in the morning, evening or as needed to support hydration within the prescribed routine.
A broad-spectrum UVA and UVB sunscreen with a matte finish. Daily sun protection is particularly important when using hydroquinone and exfoliating skincare products.
Obagi Nu-Derm Clear and Obagi Nu-Derm Blender each contain hydroquinone USP 4%, equivalent to 40mg of hydroquinone per gram of product. Hydroquinone is the active medicinal ingredient in these two creams.
The prescribing information describes topical hydroquinone as producing reversible depigmentation by inhibiting the enzymatic oxidation of tyrosine to DOPA and suppressing other metabolic processes within melanocytes. These actions reduce melanin formation within the treated area.
The presence of two hydroquinone products does not mean that the system contains or delivers an 8% hydroquinone formulation. Clear and Blender are separate 4% products used at different stages of the prescribed routine.
Nu-Derm Clear is the Step 3 hydroquinone cream and is labelled for morning and evening use. Nu-Derm Blender is the Step 5 hydroquinone cream and is associated with the evening routine.
Although both contain hydroquinone 4%, they have different formulation bases and different positions within the Nu-Derm System. They should not be treated as duplicate or interchangeable products.
The principal distinction between the two Obagi Nu-Derm Rx systems is the cleanser and exfoliating lotion:
Exfoderm is a phytic-acid exfoliating lotion formulated for combination and normal-to-dry skin. Exfoderm Forte contains glycolic and lactic acids and is formulated for normal-to-oily skin. The correct system should be selected according to skin characteristics and the prescribed programme.
The exact application quantities and frequency should follow the individual instructions supplied after consultation. A typical product sequence is structured as follows:
This sequence explains the role of each product but does not replace the individual routine provided by the prescriber. Application frequency may be adjusted according to skin response and the treatment being prescribed.
No. Tretinoin is not one of the seven products supplied in this Obagi Nu-Derm Rx Transformation System.
Some individually prescribed Nu-Derm programmes may also incorporate a separate tretinoin product. Tretinoin should not be added, combined with Blender or positioned within the routine unless it has been prescribed with specific instructions.
The prescription component of the system is based on the depigmenting action of topical hydroquinone. Clear and Blender contain the same 4% concentration but use different formulation bases and occupy different steps in the Nu-Derm routine.
The system’s other products perform supporting functions rather than acting as additional hydroquinone medicines. Exfoderm provides surface exfoliation with phytic acid, Hydrate provides moisturisation and Sun Shield SPF 50 provides broad-spectrum ultraviolet protection.
No isolated study percentage or guaranteed treatment outcome is presented here. Response depends on the type and depth of pigmentation, ultraviolet exposure, skin characteristics and adherence to the prescribed programme.
There is no single response time that applies to every type of hyperpigmentation. The prescribing information for Clear and Blender states that use should be discontinued if no improvement is seen after 8–12 weeks. Treatment should then be reviewed rather than continued indefinitely without reassessment.
The overall Nu-Derm routine may be adjusted during treatment according to response, dryness, sensitivity and the condition being treated.
Sun exposure and ultraviolet light can stimulate melanocytic activity and contribute to repigmentation. The hydroquinone prescribing information therefore describes sunscreen use as an essential aspect of treatment.
Sun Shield Matte Broad Spectrum SPF 50 should be applied as directed. Sunscreen ordinarily requires adequate application before exposure and reapplication during the day, particularly following swimming, sweating or prolonged exposure.
Clear and Blender can produce temporary redness or mild burning. The prescribing information recommends testing hydroquinone on a small area of unbroken skin before wider application. Stop using the affected product and seek advice if itching, blistering, marked inflammation or another suspected hypersensitivity reaction develops.
Clear and Blender contain sodium metabisulfite. This can cause allergic-type reactions in susceptible individuals, with sulfite sensitivity occurring more frequently in people with asthma.
Avoid contact with the eyes, nose, mouth and lips. The safety of topical hydroquinone during pregnancy and in children aged 12 or younger has not been established.
Store the products according to their individual packaging instructions. The prescribing information for Clear and Blender specifies controlled room-temperature storage between 15°C and 25°C. Keep the products out of direct sunlight.
It is a seven-product morning and evening skincare system combining two prescription hydroquinone 4% creams with cleanser, toner, exfoliating lotion, moisturiser and SPF 50 sun protection.
The Normal-to-Dry system contains Gentle Cleanser, Nu-Derm Toner, Nu-Derm Clear, Nu-Derm Exfoderm, Nu-Derm Blender, Obagi Hydrate Facial Moisturizer and Sun Shield Matte Broad Spectrum SPF 50.
This is the Normal-to-Dry system. It contains Gentle Cleanser and Exfoderm. The Normal-to-Oily system instead contains Foaming Gel and Exfoderm Forte.
Yes. Nu-Derm Clear and Nu-Derm Blender each contain hydroquinone USP 4%.
No. Clear and Blender are two separate products, each formulated with hydroquinone 4%. Their concentrations should not be added together and described as an 8% formulation.
Clear is the Step 3 hydroquinone cream used within the morning and evening routine. Blender is the Step 5 hydroquinone cream associated with the evening routine. They contain the same active concentration but have different formulation bases and uses within the system.
No. Tretinoin is not included. If tretinoin forms part of an individual Nu-Derm programme, it must be prescribed separately with its own application instructions.
Exfoderm is the morning exfoliating lotion supplied with the Normal-to-Dry system. It contains phytic acid and is different from Exfoderm Forte, the glycolic- and lactic-acid product supplied with the Normal-to-Oily system.
Dryness, redness, mild burning or surface flaking can occur, particularly when hydroquinone and exfoliating products are introduced. The application schedule may need to be adjusted according to skin response.
Duration is determined individually. The hydroquinone prescribing information states that Clear and Blender should be discontinued if no improvement is seen after 8–12 weeks and the treatment should then be reviewed.
Yes. Ultraviolet exposure can sustain melanocytic activity and contribute to repigmentation. Daily broad-spectrum sun protection is therefore an important part of the Nu-Derm programme.
Nu-Derm Rx includes prescription products containing hydroquinone 4%. Nu-Derm Fx is a separate, hydroquinone-free system that uses arbutin-based cosmetic formulations. The systems should not be treated as equivalent products.